13-03-2026, 20:54

Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates

Notified -
Globe Newswire13-03-2026, 20:54
25-02-2026, 07:30

Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)

Notified -
Globe Newswire25-02-2026, 07:30